In many countries invasive aspergillosis is the second most prevalent opportunistic mycosis in man. Its incidence is greater in patients whose immunity has been compromised by cytotoxic chemotherapy or immunosuppression after transplantation.' The onset of invasive aspergillosis may be insidious or acute, and the infection can be complicated by concurrent infections and be rapidly fatal. Diagnosis may be delayed because Aspergillus is rarely cultured from specimens before death and the importance of isolating this organism from sputum is often doubted. Biopsies of a localised lesion may show invasive aspergillosis but may be impractical owing to the patient's underlying condition.
Early diagnosis is important if the immunocompromised patient is to be successfully treated. (pH 8.6) and 1% (w/v) agarose (Litex-LSA) as previously described.'0 Non-specific precipitation was eliminated by washing the gel in 5% (w/v) trisodium citrate.
ASPERGILLUS IgG ENZYME LINKED IMMUNOSORBENT ASSAY Checkerboard analysis Two checkerboard titrations were carried out to determine the optimum assay conditions for each of the four antigens used. In the first checkerboard two serum samples from the control patients with pulmonary aspergilloma were chosen, one of which formed multiple precipitin lines and the other few. These were compared with a Trull, Parker, Warren single precipitin negative serum. Antigen, test serum, and enzyme conjugate concentrations were varied, and a narrower range of antigen and serum dilutions was selected to provide good discrimination between precipitin positive and negative sera. The optimum dilution of conjugate for development of colour within 20-40 minutes was determined.
In the second checkerboard eight precipitin positive sera were compared with eight precipitin negative sera. Concentrations of antigen and test serum were varied within the narrower ranges established in the first checkerboard. Student' s t test was applied to determine the best conditions for discriminating between precipitin positive and negative sera. Enzyme linked immunosorbent assay method Antigen at the optimum concentration (10-40,g/ml) in 100 ,ul volumes 0-05/M carbonate/bicarbonate buffer (pH 9.6) was incubated overnight at 37°C in the inner wells of flexible polyvinyl microtitre plates (Cooke, Dynatech 1-220-229). After washing three times in phosphate buffered saline (pH 7.3) 0-15 M supplemented with 0*05% (v/v) Tween 20 (phosphate buffered saline/Tween) 100 Al volumes of the test and control sera were added in duplicate to the wells at the optimum dilution (1:100 or 1:500) in phosphate buffered saline/Tween 20 supplemented with 1% (w/v) bovine serum albumin (assay buffer).
After incubation for two hours at 37°C and washing binding antibody was detected with goat antihuman IgG conjugated with alkaline phosphatase (Miles Yeda) at the optimum dilution (1:500 or 1:1000) in assay buffer. After incubation for three hours at 37°C and washing enzyme substrate (Sigma 104-105) at 1 mg/ml diethanolamine buffer (pH 9.6) was added and the colour developed for 20-40 minutes until the optical density of a previously selected positive control serum at a 1:100 dilution reached a value of 1-9-2*0. The reaction was then stopped with 3/M sodium hydroxide and the optical density of test and control samples measured spectrophotometrically at 405 nm. Standardisation of enzyme linked immunosorbent assay A singl-e positive (standard) serum from a control patient with aspergilloma was included in every assay at a range of seven dilutions between 1: 100 and 1: 10000 in assay buffer. The enzyme linked immunosorbent assay optical density reading for each dilution was plotted against the serum dilution to provide a standard curve. The optical density reading for each test sample was read off this standard curve and expressed in arbitrary units of antibody on a logarithmic scale. One hundred units of antibody were equated to a 1:100 dilution of the standard serum.
The same eight negative control sera as were used for checkerboard analysis plus one additional pre- (Fig. 1) . Sera from six patients (cases 1-6), all with disseminated disease, were positive when tested against all four antigens. Three patients (cases 7-9) were positive with three antigens, two (cases 10 and 11) with two antigens, and five (cases 12-16) with only one antigen. The diagnosis of invasive 1047 aspergillosis in the three seronegative patients rested solely on the histological identification of hyphae characteristic of Aspergillus after death: A fumigatus was never cultured from sputum or other specimens either before or after death.
Ten patients (cases 1-10) had antibodies against both somatic and culture filtrate antigens from either commercial source. The first positive response to the Bencard somatic antigen occurred before that to the culture filtrate antigen in five patients (cases 1-4 and 10), all of whom developed disseminated aspergillosis. This response usually preceded clinical features suggestive of localised or disseminated infection (Fig. 2) .
Raised IgG antibodies to one or other somatic antigen preparation were found in 10 of the 19 patients (cases 1-10), nine of whom developed disseminated infection. Antibodies to both somatic antigens were found in eight patients. All 16 seropositive patients had raised antibodies to one or both culture filtrate antigens. In five of the six patients (cases 11-16) with raised antibodies to only culture filtrate antigens the response was restricted to one or other of the two antigens. Although the magnitude of the response to culture filtrate antigens was often modest, it was associated with a more than four fold change in the antibody index (highest index/lowest index), whereas this four fold change was less common with the somatic antigens. Such large changes were not found in our patients without invasive aspergillosis who had undergone transplantation (data not shown).
Four of the 11 patients with invasive aspergillosis, from whom pretransplant sera were available, were seropositive before transplantation (cases 4, 8, 10, and 16). In two cases the earliest pretransplant antibody response was to Bencard somatic antigen, but in one case it was to Bencard culture filtrate and in the fourth it was to both Mercia Brocades antigens. Two examples are illustrated in Fig. 3 . Death followed a precipitous fall in antibodies. All four patients in this selected series with antibodies to Aspergillus before transplantation died of disseminated infection. The mean survival time after transplantation in these four patients was 51-5 (SE 12-5) days and this compared with the mean survival time of 169 (35) days in the seven patients without antibody before transplantation. This difference was significant (t = 2.44; p < 0.05).
In the 12 patients who died and were seropositive more than two weeks before death (cases 2-12 and 14) IgG antibodies to one or more Aspergillus antigens decreased and were no longer appreciably raised in the last serum sample obtained within two weeks of death (Fig. 1) Tx LC and their sera were not tested for antibodies to antigens derived from other filamentous fungi. Four out of 11 renal and hepatic transplant recipients from whom pretransplant sera were available had high IgG antibody levels before the allograft. These four patients lived for a significantly shorter time after transplantation; all four patients had disseminated infection at necropsy. Infection may, therefore, have been established before transplantation. Depending on the antigen used, between five Between four and eight of the 134 sera from leukaemic patients were positive in the enzyme linked immunosorbent assay; again the incidence depended on the antigen used. Multiple sera are now being collected from these patients so that the prospective value of this test in immunocompromised patients can be more fully assessed. These background rates, showing a prevalence of seropositivity of 3-14% in similar immunocompromised patients suggest that the high incidence of antibody responses detected in patients with invasive aspergillosis will be valuable.
There was considerable variation in the timing and magnitude of individual responses to the different preparations of antigens. The somatic antigens appear to be most useful in early rather than late detection of disseminated aspergillosis, but culture filtrate antigens detect the highest proportion of positive antibody responses. The use of both somatic and culture filtrate antigens seems necessary at present for the reliable and early diagnosis of invasive aspergillosis by Aspergillus IgG enzyme linked immunosorbent assay.
By the time invasive aspergillosis is diagnosed antibodies may have fallen to within the normal range, even in cases of fulminant disseminated disease. Similar results have been reported by others." This fall in antibody levels may explain, in part, the poor results obtained with immunoprecipitation methods used in earlier investigations of single serum samples and the poor reputation of such tests when only late diagnoses are made. It also emphasises the necessity for prospectively collecting serum samples from immunocompromised patients for the assay of antibodies to Aspergillus.
Reports suggest that a successful outcome in treating invasive aspergillosis in immunocompromised patients depends on early diagnosis and whether 1051 Aspergillus has disseminated from the lung.2 Techniques for detecting antibodies may permit earlier diagnosis, conceivably before the dissemination of Aspergillus to other organs. The impact of earlier diagnosis on the outcome of treatment with amphotericin B in chronically immunocompromised patients with invasive aspergillosis requires assessment.
